Money Talks: Why weight-loss drugs will reshape the world
Money Talks from The Economist
Expensive Drug Demand and Manufacturing Bottlenecks
The demand for expensive drugs in America is continuously increasing, with the possibility of reaching 150 million users. Despite the high price and exclusive nature of these drugs, there is no shortage of demand. However, manufacturing bottlenecks slow down supply expansion, leading to disappointment as widespread use at affordable prices could greatly improve quality of life. The speaker envisions a world where investment and coordination would allow mass production of these drugs, similar to the rapid production of COVID vaccines or wartime essentials.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
